13F
中

LENZ LENZ THERAPEUTICS INC

2026Q1 · CUSIP 52635N103 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
143
Δ holders QoQ
-18
Breadth percentile
Top 91%
Whale holders
78
Δ whales
-1
Inst. holding value
$310M
New positions
35
Closed positions
53
Price momentum (1Q)
-47.1%
Put / Call
3/3

Breadth history (34 quarters)

2024Q2: Δ+9 · h=66 2024Q3: Δ+13 · h=79 2024Q4: Δ+16 · h=95 2025Q1: Δ+12 · h=107 2025Q2: Δ+7 · h=114 2025Q3: Δ+50 · h=164 2025Q4: Δ-3 · h=161 2026Q1: Δ-18 · h=143 2024Q2: holders=66 2024Q3: holders=79 2024Q4: holders=95 2025Q1: holders=107 2025Q2: holders=114 2025Q3: holders=164 2025Q4: holders=161 2026Q1: holders=143 -50 -25 +0 +25 +50 59116173 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 4% -53.1% -72.0%

Options Sentiment

Put holders
3
QoQ: -1
Call holders
3
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-3.64
EPS YoY
-651.5%
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-06-30: EPS -0.40 2024-09-30: EPS -0.38 2025-03-31: EPS -0.53 2025-06-30: EPS -0.53 2025-09-30: EPS -0.59 2025-12-31: EPS -1.20 2026-03-31: EPS -1.32 -1.45 -0.73 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)